technology
about us
overview
leadership
team & partnership
publications
pipeline
pipeline overview
ti-168
ti-235
ti-385
ti-495
ti-520
news&media
contact
KOR
Pipeline Overview
STAGE :
1
Lead Optimazation
2
Pre-IND
3
Clinical Phase I
TI-168
FVIIITCR-Treg
HemophiliaA
TI-235
TCR-Treg
MultipleSclerosis
TI-385
BAR-Tcell
B cell lymphoma
TI-495
TCR-Treg
Xeno-transplantation
TI-520
Atopic dermatitis
